Pages

November 20, 2012

Acupuncture may be more effective at reducing migraines than Topamax

A study conducted in Taiwanhas found that acupuncture may be more effective at reducing migraine headaches than topiramate, the active ingredient in Topamax. Topamax side effects include heart and memory complications, as well as congenital birth defects among women who use the drug while pregnant.

Read more about birth defects linked to Topamax use...

November 15, 2012

Antidepressants during pregnancy carry risks, study says

According to a new review, pregnant women who take selective serotonin reuptake inhibitors (SSRIs) -- a popular type of antidepressants -- may have a greater risk of pregnancy complications, including birth defects, pre-term birth and miscarriage.

Read more about pregnancy complications linked to SSRI antidepressant use...

November 14, 2012

European regulators won’t recommend weight loss drug containing Topamax ingredient

The European Medicines Agency (EMA) has recommended not to approve a new weight loss drug containing topiramate, the active drug in Topamax. The EMA expressed concerns about the long-term risks of cardiovascular problems and other side effects associated with the drug, known as Qsymia. Topamax was recently upgraded to the FDA’s Pregnancy Category D, signifying the drug has a proven risk of causing birth defects.

Read more about the risks associated with Qsymia...